Gluten-related disorders

From Wikipedia, the free encyclopedia
  (Redirected from Gluten intolerance)
Jump to: navigation, search
Gluten-related disorders

Gluten-related disorders is the umbrella term for all diseases triggered by gluten. Gluten-related disorders include celiac disease (CD), non-celiac gluten sensitivity (NCGS), gluten ataxia, dermatitis herpetiformis (DH) and wheat allergy.[1][2] The term "gluten intolerance" should not be used, because it is non specific and carries inherent contradictions and weaknesses. Furthermore, it is not recommended to use the term "gluten sensitivity", and "non-coeliac gluten sensitivity" is to be used instead.[1]

Gluten, named from the Latin gluten meaning glue,[3] is a substance that gives elasticity to dough helping it to rise and to keep its shape. It is found in many staple foods in the Western diet.

Currently, there is a growing incidence of a wide spectrum of gluten-related disorders all around the world. It can be explained for the progressive westernization of diet, the expansion of Mediterranean diet (which includes a lot of foods that incorporate gluten), and the growing replacement of rice by wheat in many countries.[4]


The following classification of gluten-related disorders was announced 2011 by an expert's panel in London, published 2012 and further expanded on later that year:[5]

Autoimmune disorders[edit]

Autoimmune conditions related to gluten include celiac disease, dermatitis herpetiformis, and gluten ataxia. There is research showing that in certain patients with gluten ataxia early diagnosis and treatment with a gluten-free diet can improve ataxia and prevent its progression.[6] The population of patients with gluten ataxia and other neurological conditions appears to have a different HLA distribution, in particular more HLA-DQ1, compared to the population of typical celiac disease patients.[7]

Coeliac disease[edit]

Main article: Coeliac disease

Coeliac disease (American English: celiac) (CD) is a chronic, immune-mediated mainly intestinal process, caused by the ingestion of wheat, barley, rye and derivatives, that appears in genetically predisposed people of all ages. CD is not only a gastrointestinal disease, because it may involve to several organs and cause an extensive variety of non-gastrointestinal symptoms, and most importantly, it may often be completely asymptomatic.[8] Added difficulties for diagnosis are the fact that serological markers (anti-tissue transglutaminase [TG2]) are not always present[9] and many patients may have minor mucosal lesions, without atrophy of the intestinal villi.[10]

CD affects approximately 1% of general population all over the world,[11] but most cases remain unrecognized, undiagnosed and untreated, and exposed to the risk of long-term complications.[12][13] Patients may suffer severe disease symptoms and be subjected to extensive investigations for many years, before a proper diagnosis is achieved.[14] Untreated CD may cause malabsorption, reduced quality of life, iron deficiency, osteoporosis, an increased risk of intestinal lymphomas[8] and greater mortality.[15] CD is associated with some autoimmune diseases, such as diabetes mellitus type 1, thyroiditis,[16][8] gluten ataxia, psoriasis, vitiligo, autoimmune hepatitis, dermatitis herpetiformis, primary sclerosing cholangitis, and more.[16]

CD with “classic symptoms”, which include gastrointestinal manifestations such as chronic diarrhea and abdominal distention, malabsorption, lose of appetite, and impaired growth, is currently the least common presentation form of the disease and affects predominantly to small children generally younger than two years of age.[14][12]

CD with “non-classic symptoms” is the most common clinical found type[14] and occurs in older children (over 2 years old),[14] adolescents and adults.[14] It is characterized by milder or even absent gastrointestinal symptoms and a wide spectrum of non-intestinal manifestations that can involve any organ of the body, and very frequently may be completely asymptomatic[12] both in children (at least in 43 % of the cases[17]) and adults.[12]

Following a lifelong gluten-free diet is the only medically-accepted treatment for people with coeliac disease.[18][19]

Dermatitis herpetiformis[edit]

Dermatitis herpetiformis (DH), or Duhring-Brocq disease, is a chronic blistering skin autoimmune condition, characterized by the presence of skin lesions that have an extensive and symmetrical distribution, predominating in areas of greater friction, and affecting mainly both elbows, knees, buttocks, ankles, and may also affect the scalp and other parts of the body, and non-symmetrical occasionally. The lesions are vesicular-crusted and when flake off, they evolve to pigmented areas or achromic an intense burning, itchy and blistering rash.[20][21] Despite its name, DH is neither related to nor caused by herpes virus: the name means that it is a skin inflammation having an appearance similar to herpes.

The age of onset is variable starting in children and adolescence but can also affect individuals of both sexes indistinctly at any age of their lives.[21][22]

A fact that difficults its diagnosis is the relatively common presentation with atypical manifestations. Some patients may show erythema or severe pruritus alone, wheals of chronic urticaria, purpuric lesions resembling petechiae on hands and feet, palmo-plantar keratosis, leukocytoclastic vasculitis-like appearance, and/or lesions mimicking prurigo pigmentosa. DH may be confused with many different cutaneous lesions, such as atopic dermatitis, eczema, urticaria, scabies, impetigo, polymorphic erythema and other autoimmune blistering diseases.[22]

DH is considered to be as "the coeliac disease of the skin". For this reason, the new guidelines of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition for the diagnosis of coeliac disease conclude that its proven presence, by itself, confirms the diagnosis of coeliac disease. Nevertheless, duodenal biopsy is recommended in doubtful DH cases, or if there are suspected gastrointestinal complications, including lymphoma.[22] People with DH have different degrees of intestinal involvement, ranging from milder mucosal lesions to the presence of villous atrophy.[20]

The main and more efficacious treatment for DH is following a lifelong gluten-free diet, which produces the improvement of skin and gut lesions. Nevertheless, the skin lesions may take several months or even years to disappear. To calm itching, dapsone is often recommended as a temporary treatment, during the time it takes for the diet to work, but it has no effect on the gastrointestinal changes and may have important side effects.[23][20]

Non-celiac gluten sensitivity (NCGS)[edit]

Non-celiac gluten sensitivity (NCGS), or gluten sensitivity (GS),[1] is a syndrome in which patients develop a variety of intestinal and/or extraintestinal symptoms that improve when gluten is removed from the diet,[24] after coeliac disease and wheat allergy are excluded.[11] NCGS, which is possibly immune-mediated, now appears to be more common than coeliac disease,[25] with a prevalence estimated to be 6-10 times higher.[26]

Gastrointestinal symptoms, which resemble those of irritable bowel syndrome (IBS),[24][27] may include any of the following: abdominal pain, bloating, bowel habit abnormalities (either diarrhea or constipation),[28][27] nausea, aerophagia, gastroesophageal reflux disease, and aphthous stomatitis.[11][27]

Extra-intestinal symptoms, which can be the only manifestation of NCGS even in absence of gastrointestinal sympotms, may be any of the following: headache or migraine, “foggy mind”, fatigue,[11][28][27] fibromyalgia,[28][29][30] joint and muscle pain,[11][28][27] leg or arm numbness,[11][28][27] tingling of the extremities,[11][27] dermatitis (eczema or skin rash),[11][27] atopic disorders,[11] allergy to one or more inhalants, foods or metals[11][28] (such as mites mites, graminaceae, parietaria, cat or dog hair, shellfish, or nickel),[28] depression,[11][28][27] anxiety,[28] anemia,[11][27] iron-deficiency anemia, folate deficiency, asthma, rhinitis, eating disorders,[28] or autoimmune diseases.[11]

Among extra-intestinal manifestations, NCGS seems to be involved in some neuropsychiatric disorders, principally schizophrenia,[15][27] autism[28][15][27] and peripheral neuropathy,[15][27] and also ataxia[15] and attention deficit hyperactivity disorder (ADHD).[11]

Gluten is likely responsible for the appearance of symptoms, but it has been suggested than in a subgroup of patients with NCGS and symptoms like IBS, other components of wheat and related grains (oligosaccharides like fructans), or other plant proteins contained in glutencontaining cereals (agglutinins, lectins, and ATIs) may play a role in the development of gastrointestinal symptoms.[13] ATIs are about 2%-4% of the total protein in modern wheat and 80%-90% in gluten.[11] In a review of May 2015 published in Gastroenterology, Fasano et al. conclude that ATIs may be the inducers of innate immunity in people with coeliac disease or NCGS, and FODMAPs that are present in glutencontaining grains cause mild wheat intolerance at most, which is mainly limited to gastrointestinal symptoms.[11]

As occurs in patients with coeliac disease, the treatment is a gluten-free diet (GFD) strict and maintained, without making any dietary transgression.[28] Whereas coeliac disease requires adherence to a strict lifelong gluten-free diet, it is not yet known whether NCGS is a permanent, or a transient condition.[17][28] Theoretically, a trial of gluten reintroduction to observe reaction after 1-2 years of strict gluten-free diet might be advisable.[28]

Approximately, one third of NGCS patients, continue having symptoms, despite gluten withdrawal. Apart from a possible diagnostic error, there are multiple possible explanations. The main reason is a poor dietary compliance, whether voluntary and/or involuntary. Because these patients don’t suffer coeliac disease (CD), they may have the mistaken idea that they don’t need strictly following gluten-free diet, although the ingestion of even small amounts of gluten can cause more immediate and obvious symptoms in people with NGCS than those with CD. Also, patients may be inadvertently ingesting gluten, in the form of cross contamination or food containing it among their ingredients. To find out if there are unintended ingestions of gluten, it must perform an exhaustive evaluation with the advice of a CD specialized dietitian.[28]

In some cases, patients can significantly improve with a low FODMAPs diet in addition to gluten withdrawal[31] and/or a GFD with a low content of preservatives and additives.[32] Furthermore, associated to gluten sensitivity, NCGS people may often present IgE-mediated allergies to one or more foods[28] and it is estimated that around 35% of patients suffer some food intolerances, mainly lactose intolerance.[33]

Other conditions[edit]

Antibodies to α-gliadin have been significantly increased in non-celiacs individuals with oral ulceration.[34] Anti-α-gliadin antibodies are frequently found in celiac disease (CD), to a lesser degree subclinical CD, but are also found in a subset who do not have the disease. Of people with pseudo-exfoliation syndrome, 25% showed increased levels of anti-gliadin IgA.[35] One fourth of people with Sjögren's syndrome had responses to gluten, of 5 that had positive response to gluten, only one could be confirmed as CD and another was potentially GSE[clarification needed], the remaining 3 appear to be gluten-sensitive. All were HLA-DQ2 and/or DQ8-positive.[36]


More than 250 symptoms of gluten sensitivity have been reported, including bloating, abdominal discomfort or pain, constipation and diarrhea. [37] Sensitivity may also present with extraintestinal symptoms, including headache, "brain fog", tingling and/or numbness in hands and feet, fatigue, as well as muscular disturbances and bone or joint pain;[38][39][40] also neuropsychiatric manifestations ("gluten-sensitive idiopathic neuropathies") have been reported on.[41]


When enteropathy develops in early childhood, symptomatic disease is more rapidly evident. A survey of geriatrics with celiac disease in Finland revealed that the incidence of disease was much higher than the general population.[42] Allergic disease may rise or fall with age; certain evidence points to the increased or daily use of non-steroidal anti-inflammatory factors (aspirin, ibuprofen) as an increased risk factor for urticaria or anaphylaxis, and the sensitizing dose may include low-dose aspirin therapy used in the treatment of heart disease. NCGS may be a late-onset condition: in a prospective study performed among adults of 18 to 80 years, the median age of disease onset was found to be 55 years, with a six times higher prevalence in females than in males.[31]

In a recent double-blind, placebo-controlled challenge (DBPC) by Biesiekierski et al. in a few patients with IBS, the authors found no difference between gluten or placebo groups and the concept of NCGS as a syndrome was questioned. Nevertheless, probably the reintroduction of both gluten and whey protein had a nocebo effect similar in all patients, and this could have masked the true effect of gluten/wheat reintroduction.[13]

Causes of gluten sensitivity[edit]

Immunochemistry of glutens[edit]

Triticeae glutens are important factors in several inflammatory diseases. The immunochemistry can be subdivided into innate responses (direct stimulation of immune system), class II mediated presentation (HLA-DQ), class I mediated stimulation of killer cells, and antibody recognition. The responses to gluten proteins and polypeptide regions differs according to the type of gluten sensitivity. The response is also dependent on the genetic makeup of the human leukocyte antigen genes. In enteropathy, there are at least 3 types of recognition, innate immunity (a form of cellular immunity priming), HLA-DQ and antibody recognition of gliadin and transglutaminase.[43] In NCGS, there is high AGA IgG in more than half of the cases.[44] In wheat allergy, there appears to be an innate component and the response pathways are mediated through IgE against gliadin and other wheat proteins.[45][46][47]


Compared to the pathophysiology of celiac disease, the pathophysiology of NCGS is far less understood.

A literature review of 2014 found that patients suffering from NCGS "are a heterogeneous group, composed of several subgroups, each characterized by different pathogenesis and clinical history, and, probably, clinical course".[48]


Celiac disease (CD) and NCGS are closely linked with human leukocyte antigen (HLA) class II genes, HLA-DQ2 and HLA-DQ8, located on chromosome 6p21.[2] Nearly all CD patients are NLA-DQ2/HLA-DQ8 positive,[49] with 95% HLA-DQ2 and the rest usually HLA-DQ8 (which is carried by 30% of Caucasians).[2] However, the specificity of HLA-DQ2 and/or HLA-DQ8 for CD is low, with estimates ranging from 36% to 53%. In NCGS patients, the HLA-DQ2 and/or HLA-DQ8 alleles are present in only about 50%, which is still a greater proportion than in the general population.[2][49]


Studies using anti-gliadin antibodies (AGA) reveal that diagnosed or untreated[clarification needed] individuals with AGA have an increasing risk for lymphoid cancers and decreased risk for other conditions associated with affluence.[50]


A literature review of 2014 found that non-coeliac gluten sensitivity diagnosis can be reached only by excluding celiac disease (CD) and wheat allergy.[48]

Persons suspected of having celiac disease may undergo serological testing for IgA anti-tissue transglutaminase antibodies (abbreviated anti-tTG antibodies or anti-TG2 antibodies) and anti-endomysial antibodies (abbreviated EMA) provided the IgA-level is high, and if IgA is low, testing for certain IgG antibodies; in case of positive serological indication, a duodenal biopsy may confirm active celiac disease.[51]

Eliminating the possibility of CD can generally also be done by adding HLA-DQ typing. The absence of HLA-DQ2 and HLA-DQ8 has a very high negative predictive value for CD,[2][52] and the predictive value can be further enhanced by including HLA-DQ7.5 (HLA-DQ2 and HLA-DQ8 are found in coeliac disease 98% of the time in Caucasians, HLA-DQ7.5 present in the remaining 1.6% and only 0.4% of Caucasians are missed with the combination of these 3).[citation needed] Without serological or HLA-DQ2/8 positivity, celiac disease is likely not present. HLA-DQ typing has a practical advantage in that it is the only diagnostic test that allows to exclude CD when a patient is already on a gluten-free diet; however, as not only celiacs are HLA-DQ2/HLA-DQ8 positive, this method has a higher false positive rate than anti-TG2 and EMA antibody testing.

A four-of-five rule was proposed 2010 for confirming celiac disease, with the disease confirmed if at least four of the following five criteria are satisfied:[2][53]

  • typical symptoms of celiac disease;
  • positivity of serum celiac disease immunoglobulin, A class autoantibodies at high titer;
  • human leukocyte antigen (HLA)-DQ2 or DQ8 genotypes;
  • celiac enteropathy at the small bowel biopsy; and
  • response to the gluten-free diet.

For diagnosis of wheat allergy, allergy tests are available.


Main article: Gluten-free diet

For patients with celiac disease, a lifelong strict gluten-free diet is the only effective treatment to date;[18][54] for patients diagnosed with NCGS, there are still open questions concerning for example the duration of such a diet; for patients with wheat allergy, the individual average is 6 years of gluten-free diet with exception for persons with anaphylaxis for whom the diet is to be wheat-free for life.[54]

A gluten-free diet should not be started before the tests for excluding celiac disease have been performed, for the reason that the serological and biopsy tests for celiac disease are reliable only if the patient is consuming gluten.

Preferably, newly diagnosed celiacs seek the help of a dietician to receive support for identifying hidden sources of gluten, planning balanced meals, reading labels, food shopping, dining out, and dining during travel.[55] Knowledge of hidden sources of gluten is important for celiac disease patients as they need to be very strict on eating only gluten-free food; for NCGS patients, it is not certain how strict the diet needs to be.[56] Balanced eating is important because, unless particular care is taken, a gluten-free diet can be lacking in vitamins, minerals and fiber and too high in fat and calories.[57]

Gluten-free oats can provide a valuable source of fiber, vitamin B, iron, zinc and complex carbohydrates.[58] Recent studies show that gluten-sensitive individuals on a gluten-free diet often get too much simple carbohydrate, too little fiber and vitamin B. Currently most guidelines do not include oats in a gluten-free diet. While this is likely to change, oats are not recommended within a year of diagnosis because of the risk of avenin-sensitive enteropathy (ASE), the desire to establish a clinical baseline and complexity of the contamination issue.[59] Consuming oats when anti-gliadin antibodies or gliadin are present increases anti-avenin antibodies and may promote ASE, therefore duodenal biopsy may be recommended after oat consumption is initiated; the DQ phenotype of all 3 ASE individuals studied so far indicated DQ2 homozygotes are at risk for ASE.[citation needed] Guidelines are also available for the introduction of pure, uncontaminated oats into the gluten-free diet.[60]


The incidence of celiac disease and of wheat allergy is estimated each to lie at around 1% of the population. The incidence of NCGS is unknown; some estimates range from 0.6% to 6%,[54] and a systematic review of 2015 reported on studies with NCGS prevalence rates between 0.5% and 13%.[61]

In Europe, the average consumption of gluten is 10g to 20g per day, with parts of the population reaching 50g or more per day.[2]

Society and culture[edit]

Crossed-grain symbol of the Association Of European Coeliac Societies (AOECS)

In various countries, regulations and labelling requirements for gluten-free food products have been implemented.

For Europe, the Commission Regulation (EC) No. 41/2009 of 20 January 2009 concerning the composition and labelling of foodstuffs suitable for people intolerant to gluten has laid down harmonised rules on the content and labelling of these foodstuffs, setting out the conditions under which foods may be labelled as "gluten-free" or "very low gluten".[62] Having entered into force on 10 February 2009 and taken effect on 1 January 2012, these rules have been repealed with effect as of 20 July 2016. The background is that, in line with the Regulation (EU) No 609/2013 on food for specific groups, gluten-free foods shall, in future, be legislated for under the EU Food Information for Consumers Regulation (Regulation (EU) No. 1169/2011). Furthermore, the Commission Implementing Regulation (EU) No 828/2014 of 30 July 2014 on the requirements for the provision of information to consumers on the absence or reduced presence of gluten in food extends the rules of Regulation (EC) 41/2009 on "gluten-free" and "very low gluten" statements also to non pre-packed foods such as those served in restaurants. The implementing regulation also clarifies how consumers are to be informed of the difference between foods that are naturally free of gluten and products that are specially formulated for gluten-intolerant persons.[63]

Recognition of gluten-free packaged foods is facilitated by the crossed-grain symbol, representing a crossed ear of wheat. The symbol is used as a logo that facilitates food shopping for patients with CD and other gluten-related disorders. The symbol, which is protected as a trademark in Europe and the United States and is covered by worldwide copyright, can be represented in any colour.[64][65]

See also[edit]


  1. ^ a b c Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, Hadjivassiliou M, Kaukinen K, Kelly CP, Leonard JN, Lundin KE, Murray JA, Sanders DS, Walker MM, Zingone F, Ciacci C (January 2013). "The Oslo definitions for coeliac disease and related terms". Gut 62 (1): 43–52. doi:10.1136/gutjnl-2011-301346. PMC 3440559. PMID 22345659. 
  2. ^ a b c d e f g Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, Kaukinen K, Rostami K, Sanders DS, Schumann M, Ullrich R, Villalta D, Volta U, Catassi C, Fasano A (2012). "Spectrum of gluten-related disorders: consensus on new nomenclature and classification". BMC Medicine (Review) 10: 13. doi:10.1186/1741-7015-10-13. PMC 3292448. PMID 22313950. 
  3. ^ "Gluten" def. 3. Oxford English Dictionary Second Edition on CD-ROM (v. 4.0) © Oxford University Press 2009
  4. ^ Tovoli F, Masi C, Guidetti E, Negrini G, Paterini P, Bolondi L (Mar 16, 2015). "Clinical and diagnostic aspects of gluten related disorders". World J Clin Cases 3 (3): 275–84. doi:10.12998/wjcc.v3.i3.275. PMC 4360499. PMID 25789300. 
  5. ^ Czaja-Bulsa G (August 2014). "Non coeliac gluten sensitivity - A new disease with gluten intolerance". Clinical Nutrition (Edinburgh, Scotland) (Review) 34: 189–194. doi:10.1016/j.clnu.2014.08.012. PMID 25245857.  See section 9 and Figure 2: Classification of gluten-dependent disorders.
  6. ^ Hadjivassiliou M, Sanders DS, Woodroofe N, Williamson C, Grünewald RA (2008). "Gluten ataxia". Cerebellum (Review) 7 (3): 494–8. doi:10.1007/s12311-008-0052-x. PMID 18787912. 
  7. ^ Troncone R, Jabri B (June 2011). "Coeliac disease and gluten sensitivity". Journal of Internal Medicine (Review) 269 (6): 582–90. doi:10.1111/j.1365-2796.2011.02385.x. PMID 21481018. 
  8. ^ a b c Ciccocioppo R, Kruzliak P, Cangemi GC, Pohanka M, Betti E, Lauret E, Rodrigo L (Oct 22, 2015). "The Spectrum of Differences between Childhood and Adulthood Celiac Disease". Nutrients 7 (10): 8733–51. doi:10.3390/nu7105426. PMID 26506381. 
  9. ^ Fasano, A; Catassi, C (Dec 20, 2012). "Clinical practice. Celiac disease.". The New England Journal of Medicine 367 (25): 2419–26. doi:10.1056/NEJMcp1113994. PMID 23252527. 
  10. ^ Bold J, Rostami K (2011). "Gluten tolerance; potential challenges in treatment strategies". Gastroenterol Hepatol Bed Bench 4 (2): 53–7. PMC 4017406. PMID 24834157. 
  11. ^ a b c d e f g h i j k l m n o p Fasano A, Sapone A, Zevallos V, Schuppan D (May 2015). "Nonceliac gluten sensitivity". Gastroenterology 148 (6): 1195–204. doi:10.1053/j.gastro.2014.12.049. PMID 25583468. 
  12. ^ a b c d Fasano A (Apr 2005). "Clinical presentation of celiac disease in the pediatric population". Gastroenterology 128 (4 Suppl 1): S68–73. doi:10.1053/j.gastro.2005.02.015. PMID 15825129. 
  13. ^ a b c Elli L, Branchi F, Tomba C, Villalta D, Norsa L, Ferretti F, Roncoroni L, Bardella MT (Jun 2015). "Diagnosis of gluten related disorders: Celiac disease, wheat allergy and non-celiac gluten sensitivity". World J Gastroenterol 21 (23): 7110–9. doi:10.3748/wjg.v21.i23.7110. PMC 4476872. PMID 26109797. 
  14. ^ a b c d e Ludvigsson JF, Card T, Ciclitira PJ, Swift GL, Nasr I, Sanders DS, Ciacci C (Apr 2015). "Support for patients with celiac disease: A literature review". United European Gastroenterol J 3 (2): 146–59. doi:10.1177/2050640614562599. PMC 4406900. PMID 25922674. 
  15. ^ a b c d e Lebwohl B, Ludvigsson JF, Green PH (Oct 2015). "Celiac disease and non-celiac gluten sensitivity". BMJ (Review) 5: 351:h4347. doi:10.1136/bmj.h4347. PMC 4596973. PMID 26438584. 
  16. ^ a b Lundin KE, Wijmenga C (Sep 2015). "Coeliac disease and autoimmune disease-genetic overlap and screening". Nat Rev Gastroenterol Hepatol 12 (9): 507–15. doi:10.1038/nrgastro.2015.136. PMID 26303674. 
  17. ^ a b Vriezinga SL, Schweizer JJ, Koning F, Mearin ML (Sep 2015). "Coeliac disease and gluten-related disorders in childhood". Nature Reviews. Gastroenterology & Hepatology (Review) 12 (9): 527–36. doi:10.1038/nrgastro.2015.98. PMID 26100369. 
  18. ^ a b Lamacchia C, Camarca A, Picascia S, Di Luccia A, Gianfrani C (2014). "Cereal-based gluten-free food: how to reconcile nutritional and technological properties of wheat proteins with safety for celiac disease patients". Nutrients (Review) 6 (2): 575–90. doi:10.3390/nu6020575. PMC 3942718. PMID 24481131. 
  19. ^ De Palma, Giada; Nadal, Inmaculada; Collado, Maria Carmen; Sanz, Yolanda (2009). "Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects". British Journal of Nutrition 102 (8): 1154–1160. doi:10.1017/S0007114509371767. Retrieved 25 July 2013. 
  20. ^ a b c Mulder CJ, van Wanrooij RL, Bakker SF, Wierdsma N, Bouma G (2013). "Gluten-free diet in gluten-related disorders". Dig Dis. (Review) 31 (1): 57–62. doi:10.1159/000347180. PMID 23797124. 
  21. ^ a b Mendes FB, Hissa-Elian A, Abreu MA, Gonçalves VS (2013). "Review: dermatitis herpetiformis". An Bras Dermatol (Review) 88 (4): 594–9. doi:10.1590/abd1806-4841.20131775. PMC 3760935. PMID 24068131. 
  22. ^ a b c Antiga E, Caproni M (May 13, 2015). "The diagnosis and treatment of dermatitis herpetiformis". Clin Cosmet Investig Dermatol 8: 257–65. doi:10.2147/CCID.S69127. PMC 4435051. PMID 25999753. 
  23. ^ Ciacci C, Ciclitira P, Hadjivassiliou M, Kaukinen K, Ludvigsson JF, McGough N, Sanders DS, Woodward J, Leonard JN, Swift GL (Apr 2015). "The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis". United European Gastroenterol J (Review) 3 (2): 121–35. doi:10.1177/2050640614559263. PMC 4406897. PMID 25922672. 
  24. ^ a b Elli L, Roncoroni L, Bardella MT (Jul 2015). "Non-celiac gluten sensitivity: Time for sifting the grain". World J Gastroenterol (Review) 21 (27): 8221–6. doi:10.3748/wjg.v21.i27.8221. PMC 4507091. PMID 26217073. 
  25. ^ Hogg-Kollars S, Al Dulaimi D, Tait K, Rostami K (2014). "Type 1 diabetes mellitus and gluten induced disorders". Gastroenterology and Hepatology from Bed to Bench (Review) 7 (4): 189–97. PMC 4185872. PMID 25289132. 
  26. ^ Molina-Infante J, Santolaria S, Montoro M, Esteve M, Fernández-Bañares F (2014). "[Non-celiac gluten sensitivity: a critical review of current evidence] [Article in Spanish]". Gastroenterol Hepatol 37 (6): 362–71. doi:10.1016/j.gastrohep.2014.01.005. PMID 24667093. 
  27. ^ a b c d e f g h i j k l m Catassi C, Bai J, Bonaz B, Bouma G, Calabrò A, Carroccio A, Castillejo G, Ciacci C, Cristofori F, Dolinsek J, Francavilla R, Elli L, Green P, Holtmeier W, Koehler P, Koletzko S, Meinhold C, Sanders D, Schumann M, Schuppan D, Ullrich R, Vécsei A, Volta U, Zevallos V, Sapone A, Fasano A (2013). "Non-celiac gluten sensitivity: the new frontier of gluten related disorders". Nutrients (Review) 5 (10): 3839–3853. doi:10.3390/nu5103839. ISSN 2072-6643. PMID 24077239. 
  28. ^ a b c d e f g h i j k l m n o p Volta U, Caio G, De Giorgio R, Henriksen C, Skodje G, Lundin KE (Jun 2015). "Non-celiac gluten sensitivity: a work-in-progress entity in the spectrum of wheat-related disorders". Best Pract Res Clin Gastroenterol 29 (3): 477–91. doi:10.1016/j.bpg.2015.04.006. PMID 26060112. 
  29. ^ Rossi A, Di Lollo AC, Guzzo MP, Giacomelli C, Atzeni F, Bazzichi L, Di Franco M (2015). "Fibromyalgia and nutrition: what news?". Clin Exp Rheumatol 33 (1 Suppl 88): S117–25. PMID 25786053. 
  30. ^ San Mauro Martín I, Garicano Vilar E, Collado Yurrutia L, Ciudad Cabañas MJ (Dec 2014). "[Is gluten the great etiopathogenic agent of disease in the XXI century?] [Article in Spanish]" (PDF). Nutr Hosp 30 (6): 1203–10. doi:10.3305/nh.2014.30.6.7866. PMID 25433099. 
  31. ^ a b Volta U, Caio G, Tovoli F, De Giorgio R (September 2013). "Non-celiac gluten sensitivity: questions still to be answered despite increasing awareness". Cellular & Molecular Immunology (Review) 10 (5): 383–92. doi:10.1038/cmi.2013.28. PMC 4003198. PMID 23934026. 
  32. ^ Volta U, Caio G, Tovoli F, De Giorgio R (2013). "Non-celiac gluten sensitivity: questions still to be answered despite increasing awareness". Cellular and Molecular Immunology (Review) 10 (5): 383–392. doi:10.1038/cmi.2013.28. ISSN 1672-7681. PMC 4003198. PMID 23934026. Functional gastrointestinal symptoms observed in patients with NCGS as well as other disorders, including irritable bowel syndrome (IBS), could also be partly related to food additives, such as glutamates, benzoates, sulfites and nitrates, which are added to many commercial products for different reasons (to improve flavor and color and to preservative function). In general, the stronger the flavor of the food, the higher the chemical content will be. Food chemicals add strong afferent stimuli to the enteric nervous system. When patients display visceral hypersensitivity, normal physiological stimulation by such chemicals may result in exaggerated effector responses leading to luminal distension. Therefore, a low-FODMAP diet with a low content of additives and preservatives is a realistic and efficacious attempt for improving gastrointestinal symptoms in NCGS patients. 
  33. ^ Aziz I, Hadjivassiliou M, Sanders DS (Sep 2015). "The spectrum of noncoeliac gluten sensitivity". Nat Rev Gastroenterol Hepatol (Review) 12 (9): 516–26. doi:10.1038/nrgastro.2015.107. PMID 26122473. 
  34. ^ O'Farrelly C, O'Mahony C, Graeme-Cook F, Feighery C, McCartan BE, Weir DG (1991). "Gliadin antibodies identify gluten-sensitive oral ulceration in the absence of villous atrophy". J. Oral Pathol. Med. 20 (10): 476–8. doi:10.1111/j.1600-0714.1991.tb00407.x. PMID 1753350. 
  35. ^ Ringvold A, Overgaard RG (1995). "Increased IgA antibodies to gluten and gliadin in serum of persons with ocular pseudo-exfoliation". Acta ophthalmologica Scandinavica (Comparative Study) 73 (2): 171–2. doi:10.1111/j.1600-0420.1995.tb00662.x. PMID 7656149. 
  36. ^ Lidén M, Kristjánsson G, Valtýsdóttir S, Hällgren R (2007). "Gluten sensitivity in patients with primary Sjögren's syndrome". Scand. J. Gastroenterol. (Research Support, Non-U.S. Gov't) 42 (8): 962–7. doi:10.1080/00365520701195345. PMID 17613926. 
  37. ^ Korn, Danna. Living gluten-free for dummies. Hoboken, NJ: Wiley Pub., 2006. 14, 27-31. Print.
  38. ^ Sapone A, Lammers KM, Mazzarella G, et al. (2010). "Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease". Int. Arch. Allergy Immunol. (Research Support, N.I.H., Extramural) 152 (1): 75–80. doi:10.1159/000260087. PMC 2956008. PMID 19940509. 
  39. ^ Hadjivassiliou M, Chattopadhyay AK, Grünewald RA, et al. (April 2007). "Myopathy associated with gluten sensitivity". Muscle Nerve (Research Support, Non-U.S. Gov't) 35 (4): 443–50. doi:10.1002/mus.20709. PMID 17143894. 
  40. ^ Nijeboer P, Bontkes HJ, Mulder CJ, Bouma G (December 2013). "Non-celiac gluten sensitivity. Is it in the gluten or the grain?". Journal of Gastrointestinal and Liver Diseases : JGLD (Review) 22 (4): 435–40. PMID 24369326. 
  41. ^ Genuis S, Lobo RA (2014). "Gluten Sensitivity Presenting as a Neuropsychiatric Disorder". Gastroenterology Research and Practice (Review) 2014: 1–6. doi:10.1155/2014/293206. ISSN 1687-6121. PMID 24693281. 
  42. ^ Vilppula A, Collin P, Mäki M, et al. (October 2008). "Undetected coeliac disease in the elderly: a biopsy-proven population-based study". Dig Liver Dis (Research Support, Non-U.S. Gov't) 40 (10): 809–13. doi:10.1016/j.dld.2008.03.013. PMID 18467196. 
  43. ^ van Heel DA, West J (July 2006). "Recent advances in coeliac disease". Gut (Review) 55 (7): 1037–46. doi:10.1136/gut.2005.075119. PMC 1856316. PMID 16766754. 
  44. ^ Catassi C, Bai J, Bonaz B, Bouma G, Calabrò A, Carroccio A, Castillejo G, Ciacci C, Cristofori F, Dolinsek J, Francavilla R, Elli L, Green P, Holtmeier W, Koehler P, Koletzko S, Meinhold C, Sanders D, Schumann M, Schuppan D, Ullrich R, Vécsei A, Volta U, Zevallos V, Sapone A, Fasano A (2013). "Non-celiac gluten sensitivity: the new frontier of gluten related disorders". Nutrients (Review) 5 (10): 3839–3853. doi:10.3390/nu5103839. ISSN 2072-6643. PMID 24077239. 
  45. ^ Bittner C, Grassau B, Frenzel K, Baur X (March 2008). "Identification of wheat gliadins as an allergen family related to baker's asthma". Journal of Allergy and Clinical Immunology (Research Support, Non-U.S. Gov't) 121 (3): 744–9. doi:10.1016/j.jaci.2007.09.051. PMID 18036646. 
  46. ^ Matsuo H, Dahlström J, Tanaka A, et al. (February 2008). "Sensitivity and specificity of recombinant omega-5 gliadin-specific IgE measurement for the diagnosis of wheat-dependent exercise-induced anaphylaxis". Allergy (Evaluation Studies) 63 (2): 233–6. doi:10.1111/j.1398-9995.2007.01504.x. PMID 18186814. 
  47. ^ Akagawa M, Handoyo T, Ishii T, Kumazawa S, Morita N, Suyama K (August 2007). "Proteomic analysis of wheat flour allergens". Journal of Agricultural and Food Chemistry (Research Support, Non-U.S. Gov't) 55 (17): 6863–70. doi:10.1021/jf070843a. PMID 17655322. 
  48. ^ a b Mansueto P, Seidita A, D’Alcamo A, Carroccio A (2014). "Non-Celiac Gluten Sensitivity: Literature Review". Journal of the American College of Nutrition (Review) 33 (1): 39–54. doi:10.1080/07315724.2014.869996. ISSN 0731-5724. PMID 24533607. 
  49. ^ a b Sestak K, Fortgang I (October 2013). "Celiac and Non-Celiac Forms of Gluten Sensitivity: Shifting Paradigms of an Old Disease". British Microbiology Research Journal (Review) 3 (4): 585–589. doi:10.9734/BMRJ/2013/6083. PMC 4224078. PMID 25383340. 
  50. ^ Anderson LA, McMillan SA, Watson RG, et al. (2007). "Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity"". World J. Gastroenterol. (Retrospective Studies) 13 (1): 146–51. doi:10.3748/wjg.v13.i1.146. PMID 17206762. 
  51. ^ Tonutti E, Bizzaro N (2014). "Diagnosis and classification of celiac disease and gluten sensitivity". Autoimmunity Reviews (Review) 13 (4-5): 472–6. doi:10.1016/j.autrev.2014.01.043. PMID 24440147. 
  52. ^ Lundin KEA, Alaedini A, Non-celiac Gluten Sensitivity. In: Lebwohl B, Green PHR (1 November 2012). Celiac Disease, An Issue of Gastrointestinal Endoscopy Clinics. Elsevier Health Sciences. ISBN 1-4557-4735-1. 
  53. ^ Catassi C, Fasano A (August 2010). "Celiac disease diagnosis: simple rules are better than complicated algorithms". The American Journal of Medicine (Research Support, Non-U.S. Gov't) 123 (8): 691–3. doi:10.1016/j.amjmed.2010.02.019. PMID 20670718. 
  54. ^ a b c Czaja-Bulsa G (August 2014). "Non coeliac gluten sensitivity - A new disease with gluten intolerance". Clinical Nutrition (Edinburgh, Scotland) (Review) 34: 189–194. doi:10.1016/j.clnu.2014.08.012. PMID 25245857.  See Table 2: Characteristics of gluten-dependent disorders.
  55. ^ Pelkowski TD, Viera AJ (January 2014). "Celiac disease: diagnosis and management". American Family Physician 89 (2): 99–105. PMID 24444577. 
  56. ^ Cristofori F, Arezzo F, Gentile A, Francavilla R (September 2014). "Gluten Sensitivity in Pediatrics: A Clinical Conundrum". Current Pediatrics Reports 2 (3): 204–210. doi:10.1007/s40124-014-0053-9. 
  57. ^ Capili B, Chang M, Anastasi JK (October 2014). "A Clinical Update: Nonceliac Gluten Sensitivity—Is It Really the Gluten?". The Journal for Nurse Practitioners. Special Focus: Legal Matters 10 (9). pp. 666–673. 
  58. ^ Størsrud S, Hulthén LR, Lenner RA (July 2003). "Beneficial effects of oats in the gluten-free diet of adults with special reference to nutrient status, symptoms and subjective experiences". Br. J. Nutr. (Research Support, Non-U.S. Gov't) 90 (1): 101–7. doi:10.1079/BJN2003872. PMID 12844381. 
  59. ^ Rashid, Mohsin (2007-06-08). "Guidelines for Consumption of Pure and Uncontaminated Oats by Individuals with Celiac Disease". Professional Advisory Board of Canadian Celiac Association. Retrieved 2008-08-14. 
  60. ^ Rashid M, Butzner D, Burrows V, et al. (October 2007). "Consumption of pure oats by individuals with celiac disease: a position statement by the Canadian Celiac Association". Can. J. Gastroenterol. (Guideline) 21 (10): 649–51. PMC 2658132. PMID 17948135. 
  61. ^ Molina-Infante J, Santolaria S, Sanders DS, Fernández-Bañares F (2015). "Systematic review: noncoeliac gluten sensitivity". Alimentary Pharmacology & Therapeutics (Review) 41 (9): 807–20. doi:10.1111/apt.13155. PMID 25753138. 
  62. ^ "Gluten-free foodstuffs". EUR-Lex. 22 February 2011. Retrieved 4 January 2015. 
  63. ^ "Foods for people intolerant to gluten (gluten-free foods)". European Commission. Retrieved 4 January 2015. 
  64. ^ "The Crossed Grain Symbol". Coeliac UK. Retrieved 12 January 2015. 
  65. ^ "Licensing the Crossed Grain symbol". Association of European Coeliac Societies (AOECS). Retrieved 12 January 2015.